BoostPrime: a digital tool to curb cravings in opioid use disorder
Official title: BoostPrime, A Novel Digital Therapeutic for Craving Mitigation in OUD
Funded at Nxtech INC · NIH-11300988 · Data updated 2026-11-12
A smartphone app called BoostPrime helps people with opioid use disorder manage cravings and strengthen moment-to-moment self-control.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Nxtech INC NIH-funded |
| Lab location | 1 site (Houston, UNITED STATES) |
| Project start | April 15, 2023 |
| Project end | August 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $1,037,003 |
| NIH project number | 5R44DA058531-03 |
| Project ID | NIH-11300988 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults with opioid use disorder who are receiving MOUD and are open to digital cognitive training enhancements.
✕Less likely to help
Individuals not using MOUD or those without access to smartphones may not benefit.
What this research studies
This project will refine a smartphone-based software intervention that uses cognitive training exercises to reduce craving and support MOUD (medication for opioid use disorder) treatment. It plans to test adaptive, utilization-enhancing features and work with the FDA to plan regulated development. The team will conduct large-scale human testing of different platform variants to identify the best strategy for real-world use. If successful, BoostPrime could become a standard adjunct to MOUD to improve adherence and outcomes.
Why it matters
Potential benefit: If successful, BoostPrime could help people with OUD feel less craving and maintain treatment, potentially reducing relapse.
How similar studies have gone: Prior research suggests cognitive training can help with behavior change and craving management, and this platform has shown preliminary symptomatic benefits in high-utilizer groups.
Where this research is happening
-
Nxtech INC
Houston, United States Active
Researchers
- Principal investigator: Patel, Salil — Nxtech INC
- Study coordinator: Patel, Salil
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.